Clinicopathological and outcome analysis of chronic kidney disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20180313004

Enrollment

2000

Registered

2018-03-13

Start date

2018-03-09

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal inadequacy chronic kidney disease

Interventions

eGFR >90 mL/min per 1.73 m2,eGFR between 60 and 89 mL/min per 1.73 m2,eGFR between 60 and 89 mL/min per 1.73 m2,eGFR between 15 and 29mL/min per 1.73 m2,eGFR <15mL/min per 1.73 m2

Health Services Research,Health Services Research,Health Services Research,Health Services Research,Health Services Research

stage 1 CKD ,stage 2 CKD ,stage 3 CKD ,stage 4 CKD ,stage 5 CKD

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with chronic renal inadequacy

Exclusion criteria

Exclusion criteria: acute kidney disease

Design outcomes

Primary

Measure	Time frame
50% decline in eGFR one month reviewing from recorded form	—

Secondary

Measure	Time frame
ESRD one month eGFR 50 % and decrement	—

Countries

China

Contacts

Public ContactLi Tan

Li Tan

519518620@qq.com17711042464

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026